Document is current
Any future updates will be listed below
-
Authors
Benedetti, Sara
Uno, Narumi
Hoshiya, Hidetoshi
Ragazzi, Martina
Ferrari, Giulia
Kazuki, Yasuhiro
Moyle, Louise Anne
Tonlorenzi, Rossana
Lombardo, Angelo
Chaouch, Soraya
Mouly, Vincent
Moore, Marc
Popplewell, Linda
Kazuki, Kanako
Katoh, Motonobu
Naldini, Luigi https://orcid.org/0000-0002-7835-527X
Dickson, George
Messina, Graziella
Oshimura, Mitsuo
Cossu, Giulio https://orcid.org/0000-0001-5863-9593
Tedesco, Francesco Saverio https://orcid.org/0000-0001-5321-7682
-
Funding
Funding for this research was provided by:
Duchenne Parent Project
Biotechnology and Biological Sciences Research Council
Muscular Dystrophy UK (RA4/3023/1)
National Institute for Health Research (3414 (ACF))
Japan Society for the Promotion of Science (21249022)
Medical Research Council (MR/J006785/1)
Fondazione Telethon (GGP08030)
H2020 European Research Council
Seventh Framework Programme (223098 (OPTISTEM))
Seventh Framework Programme (602423 (PluriMes))
Seventh Framework Programme (262948 (Biodesign))
Fundació la Marató de TV3
Core Research for Evolutional Science and Technology
- License Information
-
More Information
Article History
Received: 2 November 2016
Revised: 7 November 2017
Accepted: 15 November 2017
First Online: 14 December 2017
Conflict of interest
: F.S.T. was principal investigator on a research grant to his institution from Takeda New Frontier Science Program, received speaking and consulting fees by Takeda Pharmaceuticals and Sanofi‐Genzyme (via UCL Consultants) and has a collaboration with GSK: all for unrelated research projects. The other authors declare that they have no conflict of interest.
